Deerfield to acquire Singular Genomics for $50m.

Synopsis

Deerfield, an investment management firm committed to advancing healthcare through investment, information and philanthropy, agreed to acquire Singular Genomics, a life science technology company, for $50m. “We are proud to support Singular Genomics as they embark on this exciting new chapter, advancing science and serving their customers with excellence,” Andrew ElBardissi, Deerfield Partner.

Principals

target

Singular Genomics Systems

bidder

Deerfield Management Company

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (2)

philip taylor

Principal at Gilmartin Group

PR Consultant

target

Deal

£ 40 M

Total Value

matt browning

‎Associate Director at SINGULAR GENOMICS SYSTEMS INC

Manager

target

Deal

£ 40 M

Total Value

Bidder Team (1)

andrew elbardissi

Partner at DEERFIELD MANAGEMENT COMPANY

Investor

bidder

Deals

£ 246 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy